Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Hindsight>Brokers' Latest TPs/ Opinions on CHINA LIFE After Quarterly Results Ann
Recommend 30 Positive 47 Negative 20 |
||||
|
||||
|
Broker│ Rating│ Target Price (HKD) JPMorgan│Overweight│40 Morgan Stanley│Overweight│37.9 CLSA│Outperform│33 –> 37 Citi│Buy│36 Goldman Sachs│Neutral│28.5 Broker | Opinion JPMorgan | Strong growth in 1Q new business value offset the negative impact from lower profit, making the Company its sector top pick Morgan Stanley | 1Q new business value surged 76%, outpacing peers; business quality continued to improve CLSA | target price for CHINA LIFE (02628.HK)'s H-shares was lifted as 1Q new business value growth significantly beat expectations and far outpaced peers Citi│ 1Q results mixed, with outstanding new business value growth, although embedded value growth was slightly lower than that of PING AN (02318.HK) Goldman Sachs│1Q net profit growth beat expectations; new business value growth was robust Auto-translated by AI AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
